Joel Greenblatt Medical Devices

Gotham Asset Management, LLC

$16.1 Billion
Q2 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade
STE Steris PLC	$24.4B	$31.2 Million 0.19% of portfolio	129,854	Q2 2025 Added 36.14%
BRKR Bruker Corp	$4.79B	$23.2 Million 0.14% of portfolio	563,277	Q2 2025 Added 334.08%
MDT Medtronic PLC	$122B	$22.5 Million 0.14% of portfolio	257,881	Q2 2025 Added 76.31%
BIO Bio Rad Laboratories, Inc.	$6.77B	$21.2 Million 0.13% of portfolio	87,863	Q2 2025 Added 208.66%
GMED Globus Medical Inc	$4.73B	$14.4 Million 0.09% of portfolio	244,076	Q2 2025 Added 91.02%
ALGN Align Technology Inc	$11B	$11.4 Million 0.07% of portfolio	60,251	Q2 2025 Added 43.42%
ABT Abbott Laboratories	$229B	$10.7 Million 0.07% of portfolio	78,430	Q2 2025 Added 39.77%
ZBH Zimmer Biomet Holdings, Inc.	$21.4B	$8.11 Million 0.05% of portfolio	88,969	Q2 2025 Added 301.85%
BSX Boston Scientific Corp	$147B	$8 Million 0.05% of portfolio	74,517	Q2 2025 Added 113.08%
DXCM Dexcom Inc	$31B	$7.28 Million 0.05% of portfolio	83,352	Q2 2025 Reduced 26.6%
PEN Penumbra Inc	$9.42B	$5.1 Million 0.03% of portfolio	19,857	Q2 2025 Added 892.85%
SYK Stryker Corp	$142B	$4.9 Million 0.03% of portfolio	12,393	Q2 2025 Added 35.24%
EW Edwards Lifesciences Corp	$47.6B	$3.39 Million 0.02% of portfolio	43,295	Q2 2025 Reduced 0.84%
CNMD Conmed Corp	$1.65B	$2.32 Million 0.01% of portfolio	44,496	Q2 2025 New
PODD Insulet Corp	$21.5B	$1.66 Million 0.01% of portfolio	5,286	Q2 2025 Reduced 41.76%
TNDM Tandem Diabetes Care Inc	$713M	$1.54 Million 0.01% of portfolio	82,432	Q2 2025 Added 20.11%
IRTC I Rhythm Technologies, Inc.	$4.87B	$1.23 Million 0.01% of portfolio	7,976	Q2 2025 New
AVNS Avanos Medical, Inc.	$502M	$834,000 0.01% of portfolio	68,166	Q2 2025 Added 207.59%
SGHT Sight Sciences, Inc.	$203M	$646,000 0.0% of portfolio	156,471	Q2 2025 Added 63.18%
AORT Artivion, Inc.	$1.74B	$457,000 0.0% of portfolio	14,720	Q2 2025 Added 22.28%
TMDX Trans Medics Group, Inc.	$4.17B	$423,000 0.0% of portfolio	3,159	Q2 2025 New
LIVN Liva Nova PLC	$2.71B	$260,000 0.0% of portfolio	5,793	Q2 2025 Reduced 79.18%
ITGR Integer Holdings Corp	$3.56B	$257,000 0.0% of portfolio	2,090	Q2 2025 Reduced 13.92%
UFPT Ufp Technologies Inc	$1.66B	$208,000 0.0% of portfolio	855	Q2 2025 New
PACB Pacific Biosciences Of California, Inc.	$272M	$44,000 0.0% of portfolio	35,671	Q2 2025 New
LUCD Lucid Diagnostics Inc.	$38.6M	$17,000 0.0% of portfolio	14,886	Q2 2025 Added 3.59%

Shares Options

Joel Greenblatt

Joel Greenblatt is the founder and managing partner of Gotham Asset Management, a successful investment firm that focuses on value investing. Greenblatt is known for his expertise in value investing and his contrarian approach to investing. He has generated strong returns for his clients over the long term.

Track Joel Greenblatt's portfolio

Track Joel Greenblatt's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.

Account